PIK3CA mutations in advanced cancers: characteristics and outcomes.
Janku F, Wheler JJ, Naing A, Stepanek VM, Falchook GS, Fu S, Garrido-Laguna I, Tsimberidou AM, Piha-Paul SA, Moulder SL, Lee JJ, Luthra R, Hong DS, Kurzrock R.
Janku F, et al. Among authors: wheler jj.
Oncotarget. 2012 Dec;3(12):1566-75. doi: 10.18632/oncotarget.716.
Oncotarget. 2012.
PMID: 23248156
Free PMC article.